FDA authorizes first over-the-counter COVID-19 test

Anyone can buy the test and collect their own sample at home.
Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox

The FDA just authorized the first over-the-counter COVID-19 test for home use.

Now, any adult who wants to can order a test kit online, collect their own sample, and mail it to a lab for analysis.

The lab delivers results in an average of 1 to 2 days after receiving the sample. The upfront cost is $119, but most insurance will pay for COVID-19 testing, at least partially.

The test’s maker, LabCorp, says it may distribute the kit through retailers, too, making it even easier to access — but there’s still room for improvement in at-home COVID-19 testing.

An Over-the-Counter COVID-19 Test

Widespread testing is absolutely key to stopping the pandemic — if everyone with COVID-19 knew they had it, they’d also know to quarantine and the infection rate would drop.

Currently, most testing is done at doctors’ offices or clinics, which might be out of reach of some people, such as those living in rural areas.

In-office testing also requires people to leave their homes, which gives the coronavirus the opportunity to spread. Healthcare workers have to spend time collecting samples and use up sometimes-limited PPE.

The FDA has authorized other at-home coronavirus test kits, but they’ve all required a doctor’s approval. This new over-the-counter COVID-19 test eliminates that barrier.

“With the first over-the-counter at-home collection kit ever authorized by the FDA for COVID-19, we are empowering people to learn about their health and make confident decisions,” LabCorp President Brian Caveney said in a press release.

“With this authorization, we can help more people get tested, reduce the spread of the virus, and improve the health of our communities,” he continued.

While it is the only over-the-counter COVID-19 test, LabCorp’s kit isn’t the ideal test to stop the spread. That would be an affordable, accurate test that delivers immediate results at home — and it actually exists (you probably can’t get it yet, though).

A Better At-Home COVID-19 Test

Tests that deliver immediate results can help decrease the coronavirus’ spread — they let a person know right away if they should be quarantining, which is something they might not otherwise do while waiting for a lab to deliver results.

Those COVID-19 tests also help eliminate processing bottlenecks at labs, which has been an ongoing problem in the U.S.

In November, the FDA authorized an at-home COVID-19 test that delivers results within 30 minutes. However, that test, made by California’s Lucira Health, is only available to a very small number of people served by two healthcare providers — and it still requires a prescription.

An over-the-counter COVID-19 test that delivers rapid results would be a game changer.

Lucira said it plans to make the test available nationwide in the spring of 2021. However, there’s currently no indication that it’ll be sold without a prescription at any point in the future.

In July, FDA Commissioner Stephen M. Hahn said that the agency was hoping to authorize an over-the-counter COVID-19 test that could deliver quick results at home and that anyone could buy at their local drugstore.

“These types of tests will be a game changer in our fight against COVID-19 and will be crucial as the nation looks toward reopening,” he said.

Five months — and nearly 150,000 COVID-19 deaths later — the U.S. public is still inexplicably waiting for that game-changing test.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Related
Potato chips or heroin? The debate on social media and mental health
Experts disagree on whether social media causes mental health issues in adolescents despite looking at the same data. Here’s why.
Scientists have invented a method to break down “forever chemicals” in our drinking water
Researchers have discovered a way to eliminate “forever chemicals,” or PFAS, which usually take hundreds or thousands of years to break down.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
What’s next for COVID-19 drugs?
Paxlovid may have underperformed in a new trial, but other promising COVID-19 drugs are being authorized or in the works.
Up Next
warm covid-19 vaccine
Subscribe to Freethink for more great stories